Scopio Labs gains De Novo clearance for AI bone marrow analysis software and more FDA clearances

Epitel received 510(k) clearance for two remote monitoring offerings and Curio Digital Therapeutics received clearance for its postpartum prescription digital therapeutic.

from MobiHealthNews https://ift.tt/qSVIB9e
https://ift.tt/AHjFsNM